LOXOFIB O LEVOFLOXACIN 250mg. IP + ORNIDAZOLE 500mg. IP

Loxofib O tablets combine levofloxacin and ornidazole for bacterial infections where anaerobic organisms may also be present. Main uses: bacterial pneumonia, including community-acquired pneumonia; acute bacterial sinusitis and acute bacterial exacerbation of chronic bronchitis; skin and skin structure infections caused by susceptible bacteria; complicated and uncomplicated urinary tract infections and acute pyelonephritis; chronic bacterial prostatitis.

Common side effects of Loxofib O Tablet include nausea; headache; diarrhoea; insomnia; constipation; dizziness. Get medical help at once if you notice tendinitis and tendon rupture; peripheral neuropathy such as numbness, tingling or burning pain in hands or feet; central nervous system effects such as seizures, confusion, tremor or mood changes.

Each Loxofib O tablet contains Levofloxacin 250 mg + Ornidazole 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Loxofib O Tablet only as your doctor advises.

The MRP of Loxofib O Tablet is ₹117.19 for a pack of 10x10 (Blister). For chemists and distributors, the PTR is ₹89.29 and the PTS is ₹80.36.

Each Loxofib O tablet contains Levofloxacin 250 mg + Ornidazole 500 mg. It comes in a pack of 10x10 (Blister).

The levofloxacin component works by interfering with the DNA of bacteria, which prevents them from growing and multiplying. The ornidazole component acts mainly on anaerobic bacteria and certain protozoa, disrupting their DNA so that these organisms cannot survive. Each ingredient works on its own group of organisms, and the doctor decides when this combination is appropriate for an infection.

Must not be used by anyone with a known allergy to levofloxacin or to other quinolone antibacterials. Must not be used by anyone with a known allergy to ornidazole or to other nitroimidazole medicines. Must not be used by patients with myasthenia gravis, as it can make muscle weakness worse. Must not be used in patients with a known prolongation of the QT interval, low blood potassium (hypokalaemia), or those taking other medicines that prolong the QT interval. Stop levofloxacin immediately and avoid all fluoroquinolones in future if disabling tendon, peripheral nerve or central nervous system effects occur; check with a doctor first if there is a history of tendon problems, seizures or nerve problems, kidney or liver disease, diabetes, or during pregnancy and breastfeeding.

Loxofib O Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.